Drug profile · INN
eslicarbazepine acetate
ZEBINIX
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
eslicarbazepine acetate (ZEBINIX) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN eslicarbazepine acetate
Brand ZEBINIX
Route ORAL
Formulation TABLET
ATC code N03AF04
Originator S.A.
Frequently asked questions
What is eslicarbazepine acetate?
eslicarbazepine acetate (ZEBINIX) is an FDA-listed pharmaceutical active ingredient. Associated with S.A.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eslicarbazepine acetate?
ZEBINIX is a marketed brand name for eslicarbazepine acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eslicarbazepine acetate?
eslicarbazepine acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.